Essai Sciences
- Company typePrivate
- Founded2017
- HeadquartersStillwater, United States
- Headcount—
- GTM typeB2B
- OfferingServices
Essai Sciences firmographics
Firmographics- Name
- Essai Sciences
- Website
- https://essaisciences.com
- Company type
- Private
- Founded year
- 2017
- Operating status
- Operating
- Ownership category
- akta.pro rank
Essai Sciences industry classification
Industry- Product category
- Biomolecular Interaction Analysis Services
- NAICS
- Other Scientific and Technical Consulting Services (54169), Other Scientific and Technical Consulting Services (541690), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
- SIC
- Services-Commercial Physical & Biological Research (8731), Services-Testing Laboratories (8734)
- akta.pro primary industry
- Reference & Esoteric Testing Laboratories (HLAFAMAJ)
Keywords
Where Essai Sciences is headquartered
LocationHeadquarters
- HQ city
- Stillwater
- HQ country
- United States
- HQ region
- North America
Markets served
Essai Sciences business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D
Essai Sciences product offering
Product offeringCore offering
Essai Sciences is a contract services provider that performs analysis of biomolecular interactions for external clients. The company offers laboratory-based testing and characterization services rather than selling a product, software platform, or instrument.
Differentiator
Problem solved
Functional benefit
Products and services
- Biomolecular Interaction Analysis Services
Companies that use Essai Sciences
Customer profileIdeal customer profiles1 record
Essai Sciences technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Essai Sciences competitors and assessment
Company assessmentDirect peers
- Reaction Biology Corp: Specialty contract research provider offering biophysical and biochemical services including SPR-based biomolecular interaction analysis. Closely comparable as a similarly sized specialist CRO in the same technical niche.
- Proteros: Specialist CRO focused on structure-based drug discovery and biophysics including SPR-based interaction analysis. Comparable as a similarly sized niche provider of contract BIA services.
- Creative Biolabs: Boutique CRO providing protein engineering and biomolecular interaction services including SPR, BLI, and ITC. Closely comparable as a similarly sized specialist serving biologics developers.
Broad incumbents
- Malvern Panalytical: Analytical instrument and service provider with biophysical characterization offerings. Comparable because it competes for the same binding-and-kinetics contract work as a service-provider peer.
- Cytiva (formerly GE Healthcare Life Sciences): Manufacturer of BIAcore SPR instruments and related lab services; sets the de facto standard for biomolecular interaction analysis. Comparable because it is both an instrument supplier and provider of fee-for-service BIA work.
- Eurofins Scientific: Global testing and contract research giant with extensive biomolecular and biophysical characterization services. Comparable because it competes for the same outsourced drug-discovery analytical work as a contract services specialist.
- WuXi AppTec: Global CRO/CDMO offering discovery, biologics, and bioanalytical services. Comparable because it sells similar contract biomolecular characterization capacity into the same pharma customer base.
- Charles River Laboratories: Large CRO offering discovery and safety services including protein-based binding and kinetics assays. Directly comparable as a buyer/competitor for biomolecular interaction contract work from pharma and biotech.
- Sartorius: Bioprocessing and lab products company with strong presence in cell-line and protein analytics including label-free interaction analysis. Comparable as both a competitor and a potential channel/acquirer for smaller BIA services firms.
Emerging players
- GenScript: Biologics services and bioassay provider that increasingly offers protein interaction and binding kinetics services. Comparable as a competitor in contract biomolecular analysis with broader biologics services as an entry point.
Market position
Customer concentration
Essai Sciences financial estimates
Financial estimateRevenue estimate
Valuation estimate
Essai Sciences leadership team
Management profileNumber of profiles
Essai Sciences funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Essai Sciences M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Essai Sciences
What does Essai Sciences do?
Essai Sciences is a contract services provider that performs analysis of biomolecular interactions for external clients. The company offers laboratory-based testing and characterization services rather than selling a product, software platform, or instrument.
When was Essai Sciences founded?
Essai Sciences was founded in 2017.
Where is Essai Sciences based?
Essai Sciences is headquartered in Stillwater, United States, in the North America region.
Who are Essai Sciences's main competitors?
Direct peers on record are Reaction Biology Corp, Proteros and Creative Biolabs. Broad incumbents are Malvern Panalytical, Cytiva (formerly GE Healthcare Life Sciences), Eurofins Scientific, WuXi AppTec, Charles River Laboratories and Sartorius. GenScript is listed as an emerging player.
Does Essai Sciences have an API?
No public API is recorded for Essai Sciences.
What industry is Essai Sciences in?
Essai Sciences's product category is Biomolecular Interaction Analysis Services. Its primary akta.pro industry code is HLAFAMAJ, Reference & Esoteric Testing Laboratories. Its NAICS code is 54169 and its SIC code is 8731.